# AEGIS Post-v1 P5 Step3 鈥?Traceable Literature Review and Integration Protocol

## Status

**POST_V1_P5_STEP3_TRACEABLE_LITERATURE_REVIEW_AND_INTEGRATION_PROTOCOL_FROZEN**

This step prospectively governs the external literature stage. It adds no literature-derived scientific claim to the manuscript and does not alter frozen AEGIS evidence.

## Review domains

The verified review will cover multimodal misinformation/fake-news detection; multimodal representation and fusion; reliability, uncertainty, calibration and selective prediction; adaptive intervention/control and selector/gating mechanisms; robustness evaluation; reproducible machine learning and experiment provenance; and information-integrity / analyst decision-support framing.

## Source hierarchy

Preference is given to peer-reviewed journal and conference papers, authoritative dataset papers, and primary institutional or standards publications where directly relevant. Preprints may be used when a peer-reviewed version is unavailable or when publication chronology materially matters, but they must be identified as preprints.

Discovery may use scholarly indexes and publisher systems, but the final ledger must verify bibliographic metadata against a stable primary or authoritative record whenever available.

## Verification rules

Every included work must have verified title, authorship, publication year, venue/source, and DOI or canonical URL when available. Manuscript claims attributed to a work must be supported by the work itself rather than inferred from its title or an aggregator snippet.

Preprint and peer-reviewed versions of the same work must not be double-counted. Retractions, corrections, and materially superseded versions must be recorded when discovered.

## Evidence separation

External literature provides field context. AEGIS repository records provide AEGIS empirical evidence. These evidence classes must remain traceably separate.

Literature may contextualize motivation, methodology, related work, limitations, and future research. It may not alter the frozen AEGIS results: validation Macro-F1 `0.8669`, `0.8716`, `0.8610`; utility-probability standard deviations `0.016633`, `0.012812`, `0.009565`; M3 `utility_probability_std >= 0.05`; M4 `active_intervention_rate > 0`; M3/M4 `NOT_SUPPORTED`; v0.35 `CORRECTION_NOT_SUPPORTED`; and v0.36 active-intervention robustness `NOT_COMPUTED`.

Official test samples remain `0`.

## Comparative-claim prohibition

This protocol does not authorize claims that AEGIS outperforms, surpasses, is more robust than, or is state of the art relative to prior systems. The frozen AEGIS validation values must not be treated as directly comparable external benchmark results without verified equivalence of dataset split, preprocessing, task definition, metric implementation, and evaluation protocol.

## Negative-result preservation

Literature integration must not dilute or reinterpret negative findings. `NOT_SUPPORTED` must not become disproven; `NOT_COMPUTED` must not become zero or a measured negative; selector failure must not become classifier non-robustness; and future AEGIS-Vision, Audio, Video, multilingual/cross-lingual, and broader multimodal work must remain outside v1.0 capability claims.

## Required next-stage artifacts

The verified literature stage must produce:

1. `p5_step4_literature_evidence_inventory.json`
2. `AEGIS_V1_VERIFIED_LITERATURE_LEDGER.md`
3. `AEGIS_V1_RELATED_WORK_SYNTHESIS.md`
4. `AEGIS_V1_MANUSCRIPT_CITATION_TRACEABILITY_LEDGER.md`
5. `AEGIS_V1_RESEARCH_MANUSCRIPT_WITH_LITERATURE.md`

Only after those artifacts pass a traceability and claim-boundary audit should the manuscript package proceed toward final closure.

## Scientific execution boundary

Model execution: **NONE**. Training: **NONE**. New scientific evaluation: **NONE**. Official-test samples accessed: **0**.
